NEW YORK (GenomeWeb News) – Abbott this week said that the US Food and Drug Administration recently approved the expanded use of the firm's RealTime HCV and RealTime HBV assay to run on the m2000 RealTime system.
Registering provides access to this and other free content.
Already have an account?Login Now.
The NIH has issued a preliminary guidance for newborn dried blood spot research.
Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.
In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.
In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.